| Similar Articles |
|---|
 |
The Motley Fool
June 7, 2005
Stephen D. Simpson |
NBTY Buys a Pipsqueak The supplement giant makes a small but strategic acquisition of Wyeth's vitamin business. Opportunistic investors might want to bone up on NBTY.   |
The Motley Fool
January 27, 2006
Stephen D. Simpson |
NBTY Makes a U-Turn While the supplement-maker's stock is up about 17%, it still wasn't a great quarter. Investors, take note. |
The Motley Fool
October 19, 2006
Brian Lawler |
Where Are The Earnings, USANA? Sales grew, but earnings didn't, compared to last year's third quarter. How much longer will the good times will last for supplement companies? It's anyone's guess, so USANA needs to start growing earnings faster and exhibiting some economies of scale. |
The Motley Fool
June 6, 2011
Patrick Martin |
Pep Up Your Portfolio With This Small Cap Keep an eye on The Vitamin Shoppe. |
The Motley Fool
June 1, 2005
Stephen D. Simpson |
Terex Builds Toward Growth Strong markets in construction and mining are helping this heavy-equipment maker. But investing in cyclical stocks can be risky. |
The Motley Fool
April 11, 2007
Rich Duprey |
Foolish Forecast: Checking USANA's Credentials The network marketer of nutritional and personal-care products is set to report its first-quarter 2007 financial results. Investors, here is what you can expect to see. |
The Motley Fool
February 25, 2008
Brian Lawler |
Supplements Take a Hit The leaders of the company which produces the supplement Enzyte are convicted of deceptive advertising. It was allowed to do this because the FDA takes the opposite approach to supplement producers that it does for pharmaceutical drugmakers. |
The Motley Fool
June 9, 2005
Richard Gibbons |
Buying on Margins Profit margins are one useful tool for finding great stock values. |
The Motley Fool
June 1, 2004
Rick Aristotle Munarriz |
GNC's Robust and Ready IPO The vitamin retailer gets ready to hit the market in a hurry. |
The Motley Fool
April 5, 2010
John Rosevear |
Earnings Rising? Sell These Stocks! The strange science of cyclical investing. |
BusinessWeek
December 20, 2004
Gene G. Marcial |
A Ruddy Glow At USANA When USANA Health Sciences fell to the low 20s in April, Jason Schrotberger of Turner Investment Partners snapped up shares -- convinced that demand for its nutritional supplements would ramp up. He was right. |
